DAIC's exclusive, specialized cardiology product comparison charts help with your purchasing decisions
January 29, 2024
Trending Charts: A Look at DAIC's Highest Viewed Comparison Charts in 2023
Did you know that Diagnostic and Interventional Cardiology (DAIC) maintains more than 40 comparison charts of product…
Read More
Concerning trend erases a decade of progress in curtailing fatal heart attacks and strokes, according to research reported in the American Journal of Preventive Medicine
January 25, 2024
Post Pandemic, US Cardiovascular Death Rate Continues Upward Trajectory
January 25, 2024 — New research confirms what public health leaders have been fearing: the significant uptick in the…
Read More
The companies will jointly support a series of educational forums among clinicians beginning later this year highlighting the significant new scientific breakthroughs that are radically transforming the traditional approach to heart disease prevention and prediction
January 25, 2024
Agepha Pharma and Caristo Diagnostics Team Up to Fight Coronary Inflammation
January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti-…
Read More
The American College of Cardiology’s Cardiovascular Summit (CV Summit) will take place on February 1-3 in Washington, DC
January 25, 2024
ACC Cardiovascular Summit Equips CV Team to Transform Care, Address Emerging Trends
January 25, 2024 — The American College of Cardiology’s Cardiovascular Summit (CV Summit) will take place on February 1…
Read More
The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias-abnormal heartbeats that start in the heart’s two lower chambers-and an elevated risk of sudden cardiac death in patients with mitral valve disease
January 24, 2024
Spotlight on Advancements in Mitral Valve Repair, Research
You may not know Carol Barr, but in the future, she could save your life.  Barr’s death at 39 from sudden cardiac…
Read More
Simona Zannetti, MD, General Manager of its Aortic business for Medtronic
January 24, 2024
Simona Zannetti, MD, Returns to Lead Medtronic Aortic Business
January 24, 2024 — Medtronic announced the recent appointment of Simona Zannetti, MD, as the General Manager of its…
Read More
While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to this guest column author who addresses the importance of identifying and reducing residual inflammatory risk.
By Robert L. Quigley, MD, DPhil
January 23, 2024
Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading…
Read More
Category I CPT code for Fractional Flow Reserve derived from computed tomography will provide broader access to HeartFlow’s AI-powered technology, a standard of care for evaluating and treating coronary artery disease
January 23, 2024
HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT
January 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) precision coronary solutions…
Read More
Data from non-randomized cohort confirms dramatic improvement in diuretic response and at least 95% reduction in loop diuretic requirements up to almost four months after last DSR therapy
January 23, 2024
Sequana Medical Announces DSMB Approval to Start Randomized MOJAVE Cohort
January 23, 2024 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and…
Read More
The International Stroke Conference 2024 will be held Feb. 7-9 in Phoenix, Arizona
January 22, 2024
International Stroke Conference 2024 to Present High-Profile Late-Breaking Science
January 23, 2024 — Focused on delivering the latest scientific advancements and new treatments in cerebrovascular…
Read More
The American College of Cardiology is again urging members of Congress to retroactively eliminate the 3.37% cut to the Medicare Physician Fee Schedule currently in effect and preserve patient access to care
January 22, 2024
ACC Disappointed by Lack of Medicare Fix in Recent Continuing Resolution
January 22, 2024 — The American College of Cardiology is again urging members of Congress to retroactively eliminate…
Read More
The American Heart Association’s 2024 Merit Award winners from Massachusetts, Pennsylvania and California will look at whether chemicals occurring in foods could be used to treat heart disease, try to unravel some of the genomic mysteries of cholesterol and assess how vaping impacts abdominal aortic aneurysms
January 22, 2024
Three Researchers Awarded $1 million Each to Study New Heart Disease Treatments, Causes
January 22, 2024 — A physician-scientist from Massachusetts researching whether chemicals naturally occurring in foods…
Read More
The American Heart Association’s 2024 Merit Award winners from Massachusetts, Pennsylvania and California will look at whether chemicals occurring in foods could be used to treat heart disease, try to unravel some of the genomic mysteries of cholesterol and assess how vaping impacts abdominal aortic aneurysms
January 22, 2024
AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)
January 22, 2024 — Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently…
Read More
Orchestra BioMed and Medtronic, Inc., have an exclusive strategic collaboration for development and commercialization of AVIM therapy for hypertensive pacemaker population, which is estimated to be more than 750,000 patients annually worldwide
January 19, 2024
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients
January 19, 2024 — Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through…
Read More
This study aims to compare the GORE VIABAHN VBX Balloon Expandable Endoprosthesis primary patency to bare metal stenting to evaluate superiority in treating complex iliac occlusive disease with the goal of informing practice guidelines around which modality is best suited for patients with this condition
January 19, 2024
First Patients Enrolled in the Gore VBX Forward Clinical Study
January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore…
Read More
Sumeet Chugh, MD, shown at work in his Cedars-Sinai laboratory
January 19, 2024
Smidt Heart Institute Sudden Cardiac Arrest Expert Receives 2024 Distinguished Scientist Award
January 19, 2024 — Heart rhythm expert Sumeet Chugh, MD, associate director of the Smidt Heart Institute at Cedars-…
Read More
Abbott's Volt PFA System is designed to overcome limitations of first-generation PFA systems by providing physicians a clearer indication of contact between the Volt PFA Catheter and targeted tissue
January 18, 2024
Abbott Announces First Global Procedures in a Clinical Trial of its Volt Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed…
Read More
First in-man experience exceeds expectations, cited as “game changer” for below-the-knee procedures
January 18, 2024
Injectable Angioplasty Balloon Catheter Transforms Peripheral Procedures, Users Report Reduced Equipment and Contrast Needs
January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for…
Read More
The American Heart Association has issued a new Policy Statement focused on the need to address structural racism as a central component to reducing cardiovascular disparities across the United States.
January 18, 2024
American Heart Association New Policy Statement: Addressing Structural Racism Central to Reducing U.S. Cardiovascular Disease Disparities
January 18, 2024 — A new American Heart Association (AHA) policy statement examines the history of structural racism,…
Read More
Physician-researcher David Ouyang, MD, to bring longstanding expertise to Journal focused on artificial intelligence and machine learning
January 17, 2024
Smidt Heart Institute Expert Named Deputy Editor of NEJM AI
January 17, 2024 — One of the Smidt Heart Institute’s leading experts in artificial intelligence, David Ouyang, MD, has…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now